GILZ inhibits the mTORC2/AKT pathway in BCR-ABL(+) cells

The malignant phenotype of chronic myeloid leukemia (CML) is due to the abnormal tyrosine kinase activity of the BCR-ABL oncoprotein, which signals several downstream cell survival pathways, including phosphoinositide 3-kinase/AKT, signal transducer and activator of transcription 5 and extracellular...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Joha, S, Nugues, A-L, Hétuin, D, Berthon, C, Dezitter, X, Dauphin, V, Mahon, F-X, Roche-Lestienne, C, Preudhomme, C, Quesnel, B, Idziorek, T
格式: Artigo
語言:Inglês
出版: Nature Publishing Group 2012
主題:
Original Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC3312406/
https://ncbi.nlm.nih.gov/pubmed/21804606
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2011.328
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍